Eric J Ende Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Eric J Ende.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Eric J Ende. Eric J Ende is Director in GENZYME CORP ($GENZ) and in PROGENICS PHARMACEUTICALS INC ($PGNX) and Director in PROGENICS PHARMACEUTICALS INC ($PGNX) and Director in AVADEL PHARMACEUTICALS PLC ($AVDL) and Director in Matinas BioPharma Holdings, Inc. ($MTNB).
Latest Insider Trading Transactions of Eric J Ende
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVDL, GENZ, MTNB, PGNX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18 2020 | AVDL | AVADEL PHARMACEUTI ... | Ende Eric J | Director | Buy | P | 5.79 | 17,000 | 98,376 | 84,900 | 67.9 K to 84.9 K (+25.04 %) |
| Aug 17 2020 | AVDL | AVADEL PHARMACEUTI ... | Ende Eric J | Director | Buy | P | 7.80 | 3,800 | 29,640 | 67,900 | 64.1 K to 67.9 K (+5.93 %) |
| Aug 17 2020 | AVDL | AVADEL PHARMACEUTI ... | Ende Eric J | Director | Buy | P | 7.74 | 1,200 | 9,288 | 64,100 | 62.9 K to 64.1 K (+1.91 %) |
| Aug 13 2020 | AVDL | AVADEL PHARMACEUTI ... | Ende Eric J | Director | Buy | P | 7.76 | 15,000 | 116,355 | 62,900 | 47.9 K to 62.9 K (+31.32 %) |
| Aug 11 2020 | AVDL | AVADEL PHARMACEUTI ... | Ende Eric J | Director | Option Exercise | A | 8.48 | 42,000 | 356,160 | 42,000 | |
| Jun 24 2020 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Buy | J | 0.00 | 3,600 | 0 | 115,292 | 111.7 K to 115.3 K (+3.22 %) |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ende Eric J | Director | Option Exercise | D | 5.01 | 16,393 | 82,129 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ende Eric J | Director | Option Exercise | D | 5.01 | 40,000 | 200,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ende Eric J | Director | Option Exercise | D | 5.01 | 16,393 | 82,129 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ende Eric J | Director | Option Exercise | D | 5.01 | 40,000 | 200,400 | 0 | |
| Dec 17 2019 | PGNX | PROGENICS PHARMACE ... | Ende Eric J | Option Exercise | A | 5.01 | 16,393 | 82,129 | 16,393 | ||
| Dec 17 2019 | PGNX | PROGENICS PHARMACE ... | Ende Eric J | Option Exercise | A | 5.01 | 40,000 | 200,400 | 40,000 | ||
| Dec 05 2019 | AVDL | AVADEL PHARMACEUTI ... | Ende Eric J | Director | Buy | P | 5.97 | 10,000 | 59,700 | 47,900 | 37.9 K to 47.9 K (+26.39 %) |
| Nov 19 2019 | AVDL | AVADEL PHARMACEUTI ... | Ende Eric J | Director | Buy | P | 4.98 | 10,000 | 49,762 | 37,900 | 27.9 K to 37.9 K (+35.84 %) |
| Nov 19 2019 | AVDL | AVADEL PHARMACEUTI ... | Ende Eric J | Director | Buy | P | 4.98 | 10,000 | 49,762 | 37,900 | 27.9 K to 37.9 K (+35.84 %) |
| Aug 22 2019 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Buy | P | 0.66 | 20,000 | 13,200 | 109,292 | 89.3 K to 109.3 K (+22.40 %) |
| Aug 21 2019 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Buy | P | 0.68 | 20,000 | 13,650 | 89,292 | 69.3 K to 89.3 K (+28.86 %) |
| Aug 21 2019 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Buy | P | 0.68 | 20,000 | 13,650 | 89,292 | 69.3 K to 89.3 K (+28.86 %) |
| Aug 09 2019 | AVDL | AVADEL PHARMACEUTI ... | Ende Eric J | Director | Option Exercise | A | 2.03 | 60,000 | 121,800 | 60,000 | |
| May 24 2019 | AVDL | AVADEL PHARMACEUTI ... | Ende Eric J | Director | Option Exercise | A | 1.49 | 8,057 | 12,005 | 8,057 | |
| May 24 2019 | AVDL | AVADEL PHARMACEUTI ... | Ende Eric J | Director | Grant | A | 0.00 | 27,900 | 0 | 27,900 | 0 to 27.9 K |
| Feb 04 2019 | AVDL | AVADEL PHARMACEUTI ... | Ende Eric J | Director | Grant | A | 0.00 | 27,900 | 0 | 27,900 | 0 to 27.9 K |
| Nov 05 2018 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Option Exercise | A | 0.74 | 128,299 | 94,941 | 128,299 | |
| Nov 05 2018 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Option Exercise | A | 0.74 | 128,299 | 94,941 | 128,299 | |
| Oct 03 2018 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Grant | A | 0.00 | 9,715 | 0 | 42,069 | 32.4 K to 42.1 K (+30.03 %) |
| Jul 11 2018 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Grant | A | 0.00 | 20,594 | 0 | 32,354 | 11.8 K to 32.4 K (+175.12 %) |
| Jun 22 2018 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Option Exercise | P | 0.50 | 12 | 6 | 12 | |
| Apr 02 2018 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Grant | A | 0.00 | 11,760 | 0 | 11,760 | 0 to 11.8 K |
| Feb 27 2018 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Option Exercise | A | 1.48 | 250,000 | 370,000 | 250,000 | |
| Apr 21 2017 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Option Exercise | A | 2.92 | 150,000 | 438,000 | 150,000 | |
| Apr 06 2011 | GENZ | GENZYME CORP | Ende Eric J | Director | Option Exercise | D | 51.52 | 7,125 | 367,080 | 0 | |
| Apr 06 2011 | GENZ | GENZYME CORP | Ende Eric J | Director | Option Exercise | M | 0.00 | 2,375 | 0 | 0 | |
| Apr 06 2011 | GENZ | GENZYME CORP | Ende Eric J | Director | Sell | D | 74.00 | 2,375 | 175,750 | 0 | 2.4 K to 0 (-100.00 %) |
| Apr 06 2011 | GENZ | GENZYME CORP | Ende Eric J | Director | Buy | M | 0.00 | 2,375 | 0 | 2,375 | 0 to 2.4 K |
| Jun 18 2010 | GENZ | GENZYME CORP | Ende Eric J | Director | Option Exercise | A | 51.52 | 7,125 | 367,080 | 7,125 | |
| Jun 18 2010 | GENZ | GENZYME CORP | Ende Eric J | Director | Option Exercise | A | 0.00 | 2,375 | 0 | 2,375 |
Page: 1